View Archive

Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Exelixis, Inc and Prometheus Laboratories Inc.

Not an official event of the 2018 ASCO Annual Meeting. Not sponsored, endorsed, or accredited by ASCO, CancerLinQ, or the Conquer Cancer Foundation.

ASCO: Matching Treatment to Patient in an Ever-Changing Era for the Management of Advanced Renal Cell Carcinoma: An Expert Tumor Board Discussion

ASCO: Matching Treatment to Patient in an Ever-Changing Era for the Management of Advanced Renal Cell Carcinoma: An Expert Tumor Board Discussion

Saturday, June 2, 2018
7:00 PM - 9:00 PM

Dinner and registration: 6:30 PM – 7:00 PM

Hilton Chicago
Salon A 1 & 2 (Lower Level)
720 S Michigan Avenue
Chicago, IL 60605

What You'll Learn:

  • The relevance of biology to mRCC treatment decisions
  • What drives decision to switch RCC therapy
  • How to manage toxicities for patients with RCC


Clinical decision- making in the setting of metastatic renal cell carcinoma (RCC) has dramatically changed over the past few years. Recent and pending approvals of new agents and combinations, as well as expanded indications, have raised questions about how rational treatment planning can be used to match the most optimal strategy to the patient. At the same time, accumulating real-world experience with newer agents and emerging trial data continue to refine state-of-the-art care is in RCC. The management of metastatic clear cell RCC (ccRCC) continues to evolve, with multiple treatment options available for patients who relapse following adjuvant surgical and tyrosine kinase inhibitor (TKI) therapy.

This activity is designed to address your key questions related to RCC management via discussion of data and real-world patient cases by a multidisciplinary faculty of internationally recognized experts in RCC. Adverse event management and future directions in the field will also be addressed and considered throughout the program in the context of the program theme, to help you individualize patient care. Foremost, this program aims to provide you with cutting-edge, practical guidance that can be applied immediately to your clinical practice.

Program Chair:

Toni K. Choueiri, MD
Director, Lank Center for Genitourinary Oncology
Director, Kidney Cancer Center
Senior Physician, Dana-Farber Cancer Institute
Jerome and Nancy Kohlberg Associate Professor of Medicine, Harvard Medical School
Boston, MA

This activity is supported by educational grants from Exelixis, Inc and Prometheus Laboratories Inc.


2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
Registration Fee - Free

Please note that attendance is on a first-come, first-served basis. Please arrive early to ensure your spot!

For registration assistance, please email, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.    

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.

Click to see all our ASCO programs!

Calendar of Events
Filter By